CD274 and head and neck squamous cell carcinoma: Cisplatin and oxaliplatin induce PD-L1 expression in some but not all murine HNSCC cells, and the therapeutic association of cisplatin or oxaliplatin with anti-PD-1 is as effective as monotherapy [73].